NB Pharma SRL
1.8 FTENB Pharma reported total assets of 745,538 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 May 2026), with 1.8 full-time equivalent.
The score of NB Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +423 % Total assets +579 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NB Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 56,725 € | ||||
| Equity | 573,958 € | ||||
| Cash | 13,228 € | ||||
| EBITDA | 107,630 € | ||||
| Total assets | 745,538 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 13 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
NB Pharma's financial analysis
- Solvency77.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NB Pharma
NB Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0465.917.724
- VAT number
- BE0465917724
- Peppol
- Registered · 0208:0465917724 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Apr 1999
- Registered office
- 8620 Nieuwpoort
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
NB Pharma (SRL) has been based in Nieuwpoort since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 56,725 € and equity of 573,958 €; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 77.0%, above the median of its sector (44.2%).
Companies similar to NB Pharma
Companies in the same business, of comparable size and area, outside its group.
- APOTHEEK op OVERSCHELDE Retail sale of pharmaceutical products Wetteren · balance sheet 745,559 €
- Depasse - Schonne Pharmacie Retail sale of pharmaceutical products Éghezée · balance sheet 747,279 €
- Pharmacie Lemmens Retail sale of pharmaceutical products Baelen · balance sheet 747,725 €
- Sdsphar Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 740,622 €
- Proxy Pharma Retail sale of pharmaceutical products Beauvechain · balance sheet 752,890 €
- D'Huyvetter - Vandermarliere Retail sale of pharmaceutical products Zulte · balance sheet 737,810 €
- Apoteek Verlinde Retail sale of pharmaceutical products Dentergem · balance sheet 734,257 €
Frequently asked questions about NB Pharma
What is the revenue of NB Pharma?
NB Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NB Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0465917724 for NB Pharma, if the company is VAT-registered. Its company number (CBE) is 0465.917.724.
Where is the registered office of NB Pharma?
According to the CBE register, the registered office of NB Pharma is in 8620 Nieuwpoort.
What is the equity of NB Pharma?
At the close of the 2025 financial year, the equity of NB Pharma amounts to 573,958 €, a solvency of 77.0% of total assets.
How many people work at NB Pharma?
1.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages NB Pharma?
The register lists 5 active mandates at NB Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NB Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →